Nexalin Technology (NXL) Cash from Investing Activities (2023 - 2026)

Nexalin Technology's (NXL) quarterly Cash from Investing Activities came in at $1.5 million in Q1 2026, up 2.44% year-on-year from $1.5 million in Q1 2025, and up 119.05% quarter-over-quarter from $689180.0 in Q4 2025.

Nexalin Technology (NXL) Cash from Investing Activities (2023 - 2026) Analysis & Trends

Nexalin Technology's Cash from Investing Activities history runs 4 years deep, the most recent figure standing at $1.5 million for Q1 2026.

  • On a quarterly basis, Cash from Investing Activities rose 2.44% year-over-year to $1.5 million in Q1 2026; TTM through Mar 2026 was -$96070.0, a 157.56% decrease from a year earlier, with the FY2025 full-year figure at -$131991.0, up 77.15% from the prior year.
  • Cash from Investing Activities climbed to $1.5 million in Q1 2026 per NXL's latest filing, from $689180.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $1.6 million in Q4 2024 and bottomed at -$4.5 million in Q3 2024.
  • The 4-year median for Cash from Investing Activities is $1.2 million (2023), against an average of $404078.5.
  • Across the five-year window, Cash from Investing Activities tumbled 639.66% in 2024 and jumped 136.25% in 2025, its largest moves.
  • Year by year, Cash from Investing Activities stood at $1.2 million in 2023, then soared by 33.09% to $1.6 million in 2024, then tumbled by 57.66% to $689180.0 in 2025, then jumped by 119.05% to $1.5 million in 2026.
  • Per Business Quant, the three latest NXL Cash from Investing Activities figures stand at $1.5 million (Q1 2026), $689180.0 (Q4 2025), and $1.6 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -20.32 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -185.00 Mn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -92.80 Mn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -298.50 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -2.50 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -475.32 Mn
10 Nexalin Technology 9.07 Mn 6.36 Mn 13,133.00 1.51 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.51 Mn
Mar 31, 2026 1.51 Mn
Dec 31, 2025 689,180.00
Dec 31, 2025 689,180.00
Sep 30, 2025 1.63 Mn
Sep 30, 2025 1.63 Mn
Jun 30, 2025 -3.92 Mn
Jun 30, 2025 -3.92 Mn
Mar 31, 2025 1.47 Mn
Mar 31, 2025 1.47 Mn
Dec 31, 2024 1.63 Mn
Dec 31, 2024 1.63 Mn
Sep 30, 2024 -4.48 Mn
Sep 30, 2024 -4.48 Mn
Jun 30, 2024 1.55 Mn
Jun 30, 2024 1.55 Mn
Mar 31, 2024 729,314.00
Mar 31, 2024 729,314.00
Dec 31, 2023 1.22 Mn
Dec 31, 2023 1.22 Mn